Considering the role of IL-7R in the generation and maintenance of memory CD8 T cells, increased expression of IL-7R on better effectors suggests that the addition of IL-7 to combination therapy or PD1-IL-2v treatment could further enhance the therapeutic efficacy of these agents against chronic viral infection and cancers. Here, PDCD1 is linked to cancer.